• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For June 22, 2023

    6/22/23 11:02:26 AM ET
    $AA
    $ADC
    $ADM
    $AES
    Aluminum
    Industrials
    Real Estate Investment Trusts
    Real Estate
    Get the next $AA alert in real time by email

    Upgrades

    For DiaMedica Therapeutics Inc (NASDAQ:DMAC), Oppenheimer upgraded the previous rating of Perform to Outperform. In the first quarter, DiaMedica Therapeutics showed an EPS of $0.20, compared to $0.13 from the year-ago quarter. At the moment, the stock has a 52-week-high of $4.05 and a 52-week-low of $1.12. DiaMedica Therapeutics closed at $3.64 at the end of the last trading period.

    For Kellogg Co (NYSE:K), Bernstein upgraded the previous rating of Underperform to Market Perform. For the first quarter, Kellogg had an EPS of $1.10, compared to year-ago quarter EPS of $1.10. At the moment, the stock has a 52-week-high of $77.16 and a 52-week-low of $63.74. Kellogg closed at $65.24 at the end of the last trading period.

    For Agree Realty Corp (NYSE:ADC), Mizuho upgraded the previous rating of Neutral to Buy. Agree Realty earned $0.98 in the first quarter, compared to $0.97 in the year-ago quarter. At the moment, the stock has a 52-week-high of $80.41 and a 52-week-low of $63.34. Agree Realty closed at $65.19 at the end of the last trading period.

    For Grab Holdings Inc (NASDAQ:GRAB), JP Morgan upgraded the previous rating of Underweight to Neutral. In the first quarter, Grab Hldgs showed an EPS of $0.06, compared to $0.11 from the year-ago quarter. At the moment, the stock has a 52-week-high of $4.03 and a 52-week-low of $2.19. Grab Hldgs closed at $3.39 at the end of the last trading period.

    For XP Inc (NASDAQ:XP), B of A Securities upgraded the previous rating of Neutral to Buy. For the first quarter, XP had an EPS of $0.28, compared to year-ago quarter EPS of $0.28. The current stock performance of XP shows a 52-week-high of $25.18 and a 52-week-low of $10.30. Moreover, at the end of the last trading period, the closing price was at $24.52.

    See all analyst ratings upgrades.

    Downgrades

    For Dow Inc (NYSE:DOW), B of A Securities downgraded the previous rating of Neutral to Underperform. For the first quarter, Dow had an EPS of $0.58, compared to year-ago quarter EPS of $2.34. At the moment, the stock has a 52-week-high of $60.88 and a 52-week-low of $42.92. Dow closed at $51.88 at the end of the last trading period.

    For The AES Corp (NYSE:AES), B of A Securities downgraded the previous rating of Buy to Neutral. In the first quarter, AES showed an EPS of $0.22, compared to $0.21 from the year-ago quarter. The current stock performance of AES shows a 52-week-high of $29.87 and a 52-week-low of $18.91. Moreover, at the end of the last trading period, the closing price was at $20.98.

    For Celanese Corp (NYSE:CE), B of A Securities downgraded the previous rating of Buy to Neutral. Celanese earned $2.01 in the first quarter, compared to $5.54 in the year-ago quarter. The stock has a 52-week-high of $128.35 and a 52-week-low of $86.73. At the end of the last trading period, Celanese closed at $108.52.

    For The Chemours Co (NYSE:CC), B of A Securities downgraded the previous rating of Buy to Neutral. Chemours earned $0.98 in the first quarter, compared to $1.46 in the year-ago quarter. The stock has a 52-week-high of $38.34 and a 52-week-low of $23.60. At the end of the last trading period, Chemours closed at $33.95.

    For Enphase Energy Inc (NASDAQ:ENPH), OTR Global downgraded the previous rating of Mixed to Negative. For the first quarter, Enphase Energy had an EPS of $1.37, compared to year-ago quarter EPS of $0.79. At the moment, the stock has a 52-week-high of $339.88 and a 52-week-low of $152.15. Enphase Energy closed at $167.99 at the end of the last trading period.

    According to BMO Capital, the prior rating for Xcel Energy Inc (NASDAQ:XEL) was changed from Outperform to Market Perform. Xcel Energy earned $0.76 in the first quarter, compared to $0.70 in the year-ago quarter. At the moment, the stock has a 52-week-high of $77.63 and a 52-week-low of $56.92. Xcel Energy closed at $62.81 at the end of the last trading period.

    According to Oppenheimer, the prior rating for Equinix Inc (NASDAQ:EQIX) was changed from Outperform to Perform. For the first quarter, Equinix had an EPS of $8.59, compared to year-ago quarter EPS of $7.16. The current stock performance of Equinix shows a 52-week-high of $792.02 and a 52-week-low of $495.11. Moreover, at the end of the last trading period, the closing price was at $768.00.

    According to Morgan Stanley, the prior rating for Tesla Inc (NASDAQ:TSLA) was changed from Overweight to Equal-Weight. In the first quarter, Tesla showed an EPS of $0.85, compared to $1.07 from the year-ago quarter. At the moment, the stock has a 52-week-high of $314.67 and a 52-week-low of $101.81. Tesla closed at $259.46 at the end of the last trading period.

    Baird downgraded the previous rating for Mercury Systems Inc (NASDAQ:MRCY) from Outperform to Neutral. Mercury Sys earned $0.40 in the third quarter, compared to $0.57 in the year-ago quarter. At the moment, the stock has a 52-week-high of $65.41 and a 52-week-low of $34.13. Mercury Sys closed at $38.10 at the end of the last trading period.

    For Eneti Inc (NYSE:NETI), Citigroup downgraded the previous rating of Buy to Neutral. Eneti earned $0.48 in the first quarter, compared to $0.37 in the year-ago quarter. At the moment, the stock has a 52-week-high of $13.46 and a 52-week-low of $5.13. Eneti closed at $11.89 at the end of the last trading period.

    According to New Street Research, the prior rating for PagSeguro Digital Ltd (NYSE:PAGS) was changed from Buy to Neutral. For the first quarter, PagSeguro Digital had an EPS of $0.23, compared to year-ago quarter EPS of $0.21. The current stock performance of PagSeguro Digital shows a 52-week-high of $19.49 and a 52-week-low of $7.51. Moreover, at the end of the last trading period, the closing price was at $10.87.

    Piper Sandler downgraded the previous rating for DigitalOcean Holdings Inc (NYSE:DOCN) from Neutral to Underweight. In the first quarter, DigitalOcean Holdings showed an EPS of $0.28, compared to $0.07 from the year-ago quarter. At the moment, the stock has a 52-week-high of $53.86 and a 52-week-low of $23.39. DigitalOcean Holdings closed at $41.38 at the end of the last trading period.

    For Alcoa Corp (NYSE:AA), Morgan Stanley downgraded the previous rating of Equal-Weight to Underweight. For the first quarter, Alcoa had an EPS of $0.23, compared to year-ago quarter EPS of $3.06. The stock has a 52-week-high of $58.19 and a 52-week-low of $31.14. At the end of the last trading period, Alcoa closed at $34.91.

    See all analyst ratings downgrades.

    Initiations

    With a Hold rating, Deutsche Bank initiated coverage on Iridium Communications Inc (NASDAQ:IRDM). The price target seems to have been set at $61.00 for Iridium Comms. In the first quarter, Iridium Comms showed an EPS of $0.08, compared to $0.02 from the year-ago quarter. The current stock performance of Iridium Comms shows a 52-week-high of $68.34 and a 52-week-low of $36.42. Moreover, at the end of the last trading period, the closing price was at $61.48.

    Citigroup initiated coverage on Everest Re Group Ltd (NYSE:RE) with a Buy rating. The price target for Everest Re Group is set to $406.00. For the first quarter, Everest Re Group had an EPS of $11.31, compared to year-ago quarter EPS of $10.31. At the moment, the stock has a 52-week-high of $395.00 and a 52-week-low of $244.67. Everest Re Group closed at $351.85 at the end of the last trading period.

    With a Buy rating, Guggenheim initiated coverage on Zura Bio Ltd (NASDAQ:ZURA). The price target seems to have been set at $20.00 for Zura Bio. The stock has a 52-week-high of $37.55 and a 52-week-low of $4.87. At the end of the last trading period, Zura Bio closed at $11.62.

    Cantor Fitzgerald initiated coverage on Humacyte Inc (NASDAQ:HUMA) with an Overweight rating. The price target for Humacyte is set to $6.00. For the first quarter, Humacyte had an EPS of $0.36, compared to year-ago quarter EPS of $0.19. The current stock performance of Humacyte shows a 52-week-high of $5.60 and a 52-week-low of $1.96. Moreover, at the end of the last trading period, the closing price was at $2.89.

    Benchmark initiated coverage on FingerMotion Inc (NASDAQ:FNGR) with a Buy rating. The price target for FingerMotion is set to $5.00. For the fourth quarter, FingerMotion had an EPS of $0.04, compared to year-ago quarter EPS of $0.04. The stock has a 52-week-high of $9.79 and a 52-week-low of $0.62. At the end of the last trading period, FingerMotion closed at $2.89.

    B. Riley Securities initiated coverage on Outbrain Inc (NASDAQ:OB) with a Neutral rating. The price target for Outbrain is set to $5.00. In the first quarter, Outbrain showed an EPS of $0.09, compared to $0.00 from the year-ago quarter. At the moment, the stock has a 52-week-high of $6.92 and a 52-week-low of $3.34. Outbrain closed at $4.80 at the end of the last trading period.

    With a Buy rating, B. Riley Securities initiated coverage on Taboola.com Ltd (NASDAQ:TBLA). The price target seems to have been set at $5.00 for Taboola.com. Taboola.com earned $0.01 in the first quarter, compared to $0.02 in the year-ago quarter. The current stock performance of Taboola.com shows a 52-week-high of $4.45 and a 52-week-low of $1.52. Moreover, at the end of the last trading period, the closing price was at $2.89.

    With a Buy rating, Mizuho initiated coverage on Terns Pharmaceuticals Inc (NASDAQ:TERN). The price target seems to have been set at $16.00 for Terns Pharma. Terns Pharma earned $0.31 in the first quarter, compared to $0.55 in the year-ago quarter. The stock has a 52-week-high of $14.04 and a 52-week-low of $1.79. At the end of the last trading period, Terns Pharma closed at $11.86.

    With a Buy rating, Stifel initiated coverage on Pembina Pipeline Corp (NYSE:PBA). The price target seems to have been set at $51.00 for Pembina Pipeline. For the first quarter, Pembina Pipeline had an EPS of $0.45, compared to year-ago quarter EPS of $0.64. The current stock performance of Pembina Pipeline shows a 52-week-high of $38.27 and a 52-week-low of $29.59. Moreover, at the end of the last trading period, the closing price was at $30.96.

    With a Neutral rating, B. Riley Securities initiated coverage on trivago NV (NASDAQ:TRVG). The price target seems to have been set at $2.00 for trivago. trivago earned $0.03 in the first quarter, compared to $0.03 in the year-ago quarter. The stock has a 52-week-high of $2.03 and a 52-week-low of $0.93. At the end of the last trading period, trivago closed at $1.15.

    B. Riley Securities initiated coverage on Despegar.com Corp (NYSE:DESP) with a Buy rating. The price target for Despegar.com is set to $10.00. Despegar.com earned $0.10 in the first quarter, compared to $0.45 in the year-ago quarter. The current stock performance of Despegar.com shows a 52-week-high of $9.10 and a 52-week-low of $4.45. Moreover, at the end of the last trading period, the closing price was at $6.98.

    With a Buy rating, B. Riley Securities initiated coverage on TripAdvisor Inc (NASDAQ:TRIP). The price target seems to have been set at $25.00 for TripAdvisor. In the first quarter, TripAdvisor showed an EPS of $0.05, compared to $0.09 from the year-ago quarter. The stock has a 52-week-high of $28.05 and a 52-week-low of $14.38. At the end of the last trading period, TripAdvisor closed at $16.11.

    With a Buy rating, DA Davidson initiated coverage on The Toro Co (NYSE:TTC). The price target seems to have been set at $117.00 for Toro. In the second quarter, Toro showed an EPS of $1.58, compared to $1.25 from the year-ago quarter. The stock has a 52-week-high of $117.66 and a 52-week-low of $72.06. At the end of the last trading period, Toro closed at $97.79.

    B. Riley Securities initiated coverage on Expedia Group Inc (NASDAQ:EXPE) with a Buy rating. The price target for Expedia Group is set to $160.00. In the first quarter, Expedia Group showed an EPS of $0.20, compared to $0.47 from the year-ago quarter. The current stock performance of Expedia Group shows a 52-week-high of $124.95 and a 52-week-low of $82.39. Moreover, at the end of the last trading period, the closing price was at $105.01.

    DA Davidson initiated coverage on Caterpillar Inc (NYSE:CAT) with a Neutral rating. The price target for Caterpillar is set to $263.00. In the first quarter, Caterpillar showed an EPS of $4.91, compared to $2.88 from the year-ago quarter. The current stock performance of Caterpillar shows a 52-week-high of $266.04 and a 52-week-low of $160.66. Moreover, at the end of the last trading period, the closing price was at $241.48.

    Stifel initiated coverage on PPL Corp (NYSE:PPL) with a Buy rating. The price target for PPL is set to $51.00. In the first quarter, PPL showed an EPS of $0.48, compared to $0.41 from the year-ago quarter. At the moment, the stock has a 52-week-high of $31.74 and a 52-week-low of $23.47. PPL closed at $26.89 at the end of the last trading period.

    Roth MKM initiated coverage on Bunge Ltd (NYSE:BG) with a Buy rating. The price target for Bunge is set to $138.00. For the first quarter, Bunge had an EPS of $3.26, compared to year-ago quarter EPS of $4.26. At the moment, the stock has a 52-week-high of $106.99 and a 52-week-low of $80.47. Bunge closed at $91.82 at the end of the last trading period.

    With a Buy rating, Roth MKM initiated coverage on Andersons Inc (NASDAQ:ANDE). The price target seems to have been set at $55.00 for Andersons. Andersons earned $0.20 in the first quarter, compared to $0.18 in the year-ago quarter. The stock has a 52-week-high of $46.48 and a 52-week-low of $29.38. At the end of the last trading period, Andersons closed at $44.97.

    With a Buy rating, Roth MKM initiated coverage on Archer-Daniels Midland Co (NYSE:ADM). The price target seems to have been set at $92.00 for Archer-Daniels Midland. In the first quarter, Archer-Daniels Midland showed an EPS of $2.09, compared to $1.90 from the year-ago quarter. At the moment, the stock has a 52-week-high of $98.28 and a 52-week-low of $69.92. Archer-Daniels Midland closed at $73.46 at the end of the last trading period.

    With an Outperform rating, Wedbush initiated coverage on TScan Therapeutics Inc (NASDAQ:TCRX). The price target seems to have been set at $8.00 for TScan Therapeutics. In the first quarter, TScan Therapeutics showed an EPS of $0.93, compared to $0.67 from the year-ago quarter. At the moment, the stock has a 52-week-high of $6.03 and a 52-week-low of $1.47. TScan Therapeutics closed at $2.84 at the end of the last trading period.

    See all analyst ratings initiations.

    Get the next $AA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AA
    $ADC
    $ADM
    $AES

    CompanyDatePrice TargetRatingAnalyst
    Tesla Inc.
    $TSLA
    2/12/2026$550.00Buy
    Tigress Financial
    Zura Bio Limited
    $ZURA
    2/9/2026$15.00Outperform
    Wedbush
    Terns Pharmaceuticals Inc.
    $TERN
    2/9/2026$58.00Outperform
    Leerink Partners
    Andersons Inc.
    $ANDE
    2/5/2026$75.00Buy
    The Benchmark Company
    Andersons Inc.
    $ANDE
    2/5/2026Buy
    The Benchmark Company
    DigitalOcean Holdings Inc.
    $DOCN
    2/5/2026$68.00Neutral → Overweight
    Cantor Fitzgerald
    Celanese Corporation
    $CE
    2/5/2026$86.00Hold → Buy
    Jefferies
    Enphase Energy Inc.
    $ENPH
    2/4/2026$52.00Hold → Buy
    HSBC Securities
    More analyst ratings

    $AA
    $ADC
    $ADM
    $AES
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Jana Partners Management, Lp sold $32,400,000 worth of shares (400,000 units at $81.00) (SEC Form 4)

    4 - MERCURY SYSTEMS INC (0001049521) (Issuer)

    2/11/26 9:45:20 PM ET
    $MRCY
    Electrical Products
    Technology

    Chief Human Resources Officer Bryant Lisa returned $38,464 worth of shares to the company (1,199 units at $32.08), decreasing direct ownership by 5% to 20,898 units (SEC Form 4)

    4 - DOW INC. (0001751788) (Issuer)

    2/11/26 7:00:53 PM ET
    $DOW
    Major Chemicals
    Industrials

    Chief Tech & Sustainability Argenton Andre returned $23,322 worth of shares to the company (727 units at $32.08), decreasing direct ownership by 1% to 38,632 units (SEC Form 4)

    4 - DOW INC. (0001751788) (Issuer)

    2/11/26 7:00:44 PM ET
    $DOW
    Major Chemicals
    Industrials

    $AA
    $ADC
    $ADM
    $AES
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Tripadvisor, Inc. Earnings Press Release Available on Company's Investor Relations Site

    NEEDHAM, Mass., Feb. 12, 2026 /PRNewswire/ -- Tripadvisor, Inc. (NASDAQ:TRIP) issued its fourth quarter and full year 2025 earnings press release which is available now at ir.tripadvisor.com. This release is also available on the SEC website at www.sec.gov. As announced previously, the company will host a conference call this morning, Thursday, February 12, 2026, at 8:30 a.m. ET to discuss the results. The live webcast and replay will be available to the public at ir.tripadvisor.com/events-and-presentations. Replays of the webcast will be accessible for at least three months following the conference call.

    2/12/26 7:05:00 AM ET
    $TRIP
    Computer Software: Programming Data Processing
    Technology

    Iridium Announces 2025 Results; Issues 2026 Outlook

    MCLEAN, Va., Feb. 12, 2026 /PRNewswire/ -- Iridium Communications Inc. (NASDAQ:IRDM) ("Iridium"), a leading provider of global voice, data, and PNT satellite services, today reported financial results for the fourth quarter and full-year 2025 and issued its full-year 2026 guidance. Iridium reported fourth-quarter 2025 total revenue of $212.9 million, which consisted of $158.9 million of service revenue and $54.0 million of revenue related to equipment sales and engineering and support projects. Total revenue was in line with last year's comparable period, in part due to an inc

    2/12/26 7:01:00 AM ET
    $IRDM
    Telecommunications Equipment
    Telecommunications

    Celanese Corporation Declares Quarterly Dividend of $0.03 Per Share

    Celanese Corporation (NYSE:CE), a global chemical and specialty materials company, today declared a quarterly cash dividend of $0.03 per share on its common stock, payable March 10, 2026. The dividend is payable to stockholders of record as of February 24, 2026. About Celanese Celanese is a global leader in chemistry, producing specialty material solutions used across most major industries and consumer applications. Our businesses use our chemistry, technology and commercial expertise to create value for our customers, employees and shareholders. We support sustainability by responsibly managing the materials we create and growing our portfolio of sustainable products to meet customer

    2/11/26 4:15:00 PM ET
    $CE
    Major Chemicals
    Industrials

    $AA
    $ADC
    $ADM
    $AES
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mcatee David R Ii bought $486,720 worth of shares (7,500 units at $64.90) (SEC Form 4)

    4 - Archer-Daniels-Midland Co (0000007084) (Issuer)

    2/9/26 5:27:53 PM ET
    $ADM
    Packaged Foods
    Consumer Staples

    President & CEO Kothandaraman Badrinarayanan bought $259,884 worth of shares (5,000 units at $51.98) (SEC Form 4)

    4 - Enphase Energy, Inc. (0001463101) (Issuer)

    2/5/26 4:41:25 PM ET
    $ENPH
    Semiconductors
    Technology

    CHIEF FINANCIAL OFFICER Coughenour Peter bought $34,900 worth of shares (500 units at $69.80), increasing direct ownership by 3% to 18,544 units (SEC Form 4)

    4 - AGREE REALTY CORP (0000917251) (Issuer)

    1/13/26 6:59:15 AM ET
    $ADC
    Real Estate Investment Trusts
    Real Estate

    $AA
    $ADC
    $ADM
    $AES
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Terns Pharmaceuticals Inc.

    SCHEDULE 13G - Terns Pharmaceuticals, Inc. (0001831363) (Subject)

    2/12/26 9:14:38 AM ET
    $TERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by Iridium Communications Inc

    10-K - Iridium Communications Inc. (0001418819) (Filer)

    2/12/26 7:01:42 AM ET
    $IRDM
    Telecommunications Equipment
    Telecommunications

    TripAdvisor Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - TripAdvisor, Inc. (0001526520) (Filer)

    2/12/26 7:01:29 AM ET
    $TRIP
    Computer Software: Programming Data Processing
    Technology

    $AA
    $ADC
    $ADM
    $AES
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Tigress Financial resumed coverage on Tesla with a new price target

    Tigress Financial resumed coverage of Tesla with a rating of Buy and set a new price target of $550.00

    2/12/26 10:13:29 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Wedbush initiated coverage on Zura Bio Limited with a new price target

    Wedbush initiated coverage of Zura Bio Limited with a rating of Outperform and set a new price target of $15.00

    2/9/26 6:54:14 AM ET
    $ZURA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Leerink Partners initiated coverage on Terns Pharmaceuticals with a new price target

    Leerink Partners initiated coverage of Terns Pharmaceuticals with a rating of Outperform and set a new price target of $58.00

    2/9/26 6:54:14 AM ET
    $TERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AA
    $ADC
    $ADM
    $AES
    Financials

    Live finance-specific insights

    View All

    Tripadvisor, Inc. Earnings Press Release Available on Company's Investor Relations Site

    NEEDHAM, Mass., Feb. 12, 2026 /PRNewswire/ -- Tripadvisor, Inc. (NASDAQ:TRIP) issued its fourth quarter and full year 2025 earnings press release which is available now at ir.tripadvisor.com. This release is also available on the SEC website at www.sec.gov. As announced previously, the company will host a conference call this morning, Thursday, February 12, 2026, at 8:30 a.m. ET to discuss the results. The live webcast and replay will be available to the public at ir.tripadvisor.com/events-and-presentations. Replays of the webcast will be accessible for at least three months following the conference call.

    2/12/26 7:05:00 AM ET
    $TRIP
    Computer Software: Programming Data Processing
    Technology

    Iridium Announces 2025 Results; Issues 2026 Outlook

    MCLEAN, Va., Feb. 12, 2026 /PRNewswire/ -- Iridium Communications Inc. (NASDAQ:IRDM) ("Iridium"), a leading provider of global voice, data, and PNT satellite services, today reported financial results for the fourth quarter and full-year 2025 and issued its full-year 2026 guidance. Iridium reported fourth-quarter 2025 total revenue of $212.9 million, which consisted of $158.9 million of service revenue and $54.0 million of revenue related to equipment sales and engineering and support projects. Total revenue was in line with last year's comparable period, in part due to an inc

    2/12/26 7:01:00 AM ET
    $IRDM
    Telecommunications Equipment
    Telecommunications

    Celanese Corporation Declares Quarterly Dividend of $0.03 Per Share

    Celanese Corporation (NYSE:CE), a global chemical and specialty materials company, today declared a quarterly cash dividend of $0.03 per share on its common stock, payable March 10, 2026. The dividend is payable to stockholders of record as of February 24, 2026. About Celanese Celanese is a global leader in chemistry, producing specialty material solutions used across most major industries and consumer applications. Our businesses use our chemistry, technology and commercial expertise to create value for our customers, employees and shareholders. We support sustainability by responsibly managing the materials we create and growing our portfolio of sustainable products to meet customer

    2/11/26 4:15:00 PM ET
    $CE
    Major Chemicals
    Industrials

    $AA
    $ADC
    $ADM
    $AES
    Leadership Updates

    Live Leadership Updates

    View All

    PPL Corporation Announces 2026 Virtual Annual Meeting

    ALLENTOWN, Pa., Feb. 6, 2026 /PRNewswire/ -- PPL Corporation (NYSE:PPL) announced today that the company's 2026 Annual Meeting of Shareowners will be held virtually. The Annual Meeting will convene live via the internet on Wednesday, May 13, 2026, at 9 a.m. Eastern Time. Shareowners of record as of March 4, 2026, are eligible to vote and participate in the Annual Meeting. Instructions on how to join the meeting will be included in proxy materials that will be provided to shareowners. About PPL PPL Corporation (NYSE:PPL), headquartered in Allentown, Pennsylvania, is a leading U

    2/6/26 7:30:00 AM ET
    $PPL
    Electric Utilities: Central
    Utilities

    Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer

    Zura Bio Limited (NASDAQ:ZURA) ("Zura" or the "Company"), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious and debilitating autoimmune and inflammatory diseases, today announced the appointment of Sandeep Kulkarni, M.D. as Chief Executive Officer (CEO), effective January 21, 2026. Dr. Kulkarni will also continue serving as a Director of Zura. Dr. Kulkarni succeeds Kim Davis, J.D., who has served as Interim CEO since October 2025 following the commencement of a medical leave of absence by CEO Robert Lisicki. Mr. Lisicki is resigning as CEO and as a Director, effective as of January 21, 2026. Ms.

    1/21/26 8:50:00 AM ET
    $ZURA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    DigitalOcean Appoints Vinay Kumar as Chief Product and Technology Officer

    DigitalOcean (NYSE:DOCN) today announced the appointment of Vinay Kumar as Chief Product and Technology Officer (CPTO). In this role, Vinay will lead product strategy, product development, cloud infrastructure, and security, with responsibility for defining and executing DigitalOcean's platform roadmap as the company scales its AI inference cloud and core cloud offerings. Vinay brings more than a decade of senior leadership experience building, operating, and scaling large-scale cloud platforms and mission-critical infrastructure. He was one of the founding members of Oracle Cloud Infrastructure (OCI), where he helped build and scale OCI from inception into a global hyperscale cloud platf

    1/20/26 8:05:00 AM ET
    $DOCN
    Computer Software: Programming Data Processing
    Technology

    $AA
    $ADC
    $ADM
    $AES
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Celanese Corporation

    SC 13G/A - Celanese Corp (0001306830) (Subject)

    12/6/24 12:11:25 PM ET
    $CE
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Celanese Corporation

    SC 13G/A - Celanese Corp (0001306830) (Subject)

    12/5/24 2:20:23 PM ET
    $CE
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13D/A filed by Humacyte Inc.

    SC 13D/A - Humacyte, Inc. (0001818382) (Subject)

    11/20/24 7:10:08 PM ET
    $HUMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care